SHAW, K.; AMSTUTZ, U.; CASTRO-PASTRANA, L.; LOO, T. T.; ROSS, C. J.; ITO, S.; RIEDER, M. J.; MAHER, M.; MACLEOD, S.; KOREN, G.; HAYDEN, M. R.; CARLETON, B. C. PHARMACOGENOMIC INVESTIGATION OF ADVERSE DRUG REACTIONS (ADRS): THE ADR PRIORITIZATION TOOL, APT. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 20, n. 2, 2018. Disponível em: Acesso em: 27 sep. 2022.